Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices. It also provides containers for the delivery of tablets and powders, liquid dosages, ophthalmic and rhinological applications, parenteral packaging applications, oral prescription medications, and cosmetics. The Primary Packaging Glass division offers glass primary packaging for medicines and cosmetics, such as ampoules, cartridges, vials, syrup and dropper bottles, tablet jars, and wide-neck jars, as well as injection, infusion, and transfusion bottles; flacons and pots for fragrances, deodorants, and care and decorative cosmetics; and bottles and jars for spirits and food. The Advanced Technologies division develops drug delivery products and platforms, such as micro pumps, which are used to self-administer medication for diabetes or Parkinson's for pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
CIKN/A
Phone49 211 6181 00
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees9,867
Next Earnings DateN/A
OptionableNot Optionable
Gerresheimer (OTCMKTS:GRRMF) Frequently Asked Questions
What is Gerresheimer's stock symbol?
Gerresheimer trades on the OTCMKTS under the ticker symbol "GRRMF."
What is the consensus analysts' recommendation for Gerresheimer?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Gerresheimer in the last year. There are currently 1 sell rating for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Gerresheimer.
Has Gerresheimer been receiving favorable news coverage?
News stories about GRRMF stock have been trending somewhat negative on Friday, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Gerresheimer earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Gerresheimer.
Who are Gerresheimer's key executives?
Gerresheimer's management team includes the folowing people:
- Mr. Dietmar Siemssen, CEO & Member of Management Board (Age 56)
- Dr. Lukas Burkhardt, Member of Management Board (Age 40)
- Ms. Katja Schnitzler, Group Director of Bus. Excellence & Continuous Improvement and Member of the Supervisory Board (Age 38)
- Ms. Severine Camp, Corp. Sr. Director of Investor Relations
- Mr. Jens Kürten, Group Sr. Director of Communication & Marketing and Press Officer of Corp. Media
How do I buy shares of Gerresheimer?
Shares of GRRMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Gerresheimer's stock price today?
One share of GRRMF stock can currently be purchased for approximately $76.44.
What is Gerresheimer's official website?
How can I contact Gerresheimer?
The company can be reached via phone at 49 211 6181 00.
MarketBeat Community Rating for Gerresheimer (OTCMKTS GRRMF)
MarketBeat's community ratings are surveys of what our community members think about Gerresheimer and other stocks. Vote "Outperform" if you believe GRRMF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GRRMF will underperform the S&P 500 over the long term. You may vote once every thirty days.
